{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:02:46Z","timestamp":1770991366502,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Doctoral Program of the First Affiliated Hospital of Chongqing Medical University","award":["CYYY- BSYJSKYCXXM202421"],"award-info":[{"award-number":["CYYY- BSYJSKYCXXM202421"]}]},{"name":"Youth Medical Research and Innovation Project of Sichuan Medical Association","award":["Q21011"],"award-info":[{"award-number":["Q21011"]}]},{"name":"Key Project of Chongqing Technology Innovation and Application Development Special Project","award":["CSTB2023TIAD-KPX0053"],"award-info":[{"award-number":["CSTB2023TIAD-KPX0053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04169-7","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:23:49Z","timestamp":1768915429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Loss of biomechanical features reveals smooth muscle disruption and disease progression in prostate cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Yu","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixiong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingke","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangdong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jindong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"10","key":"4169_CR1","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer EM, et al. Prostate Cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(10):1067\u201396.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"4169_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4169_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","volume":"11","author":"AJ Chang","year":"2014","unstructured":"Chang AJ, et al. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014;11(6):308\u201323.","journal-title":"Nat Rev Clin Oncol"},{"issue":"18","key":"4169_CR4","doi-asserted-by":"publisher","first-page":"e2305724","DOI":"10.1002\/advs.202305724","volume":"11","author":"X Bian","year":"2024","unstructured":"Bian X, et al. Integration analysis of Single-Cell Multi-Omics reveals prostate cancer heterogeneity. Adv Sci (Weinh). 2024;11(18):e2305724.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4169_CR5","first-page":"21","volume":"11","author":"DC Feng","year":"2024","unstructured":"Feng DC, et al. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy. Mil Med Res. 2024;11(1):21.","journal-title":"Mil Med Res"},{"issue":"9","key":"4169_CR6","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s43018-024-00787-0","volume":"5","author":"J Fernandez-Mateos","year":"2024","unstructured":"Fernandez-Mateos J, et al. Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer. Nat Cancer. 2024;5(9):1334\u201351.","journal-title":"Nat Cancer"},{"issue":"3","key":"4169_CR7","doi-asserted-by":"publisher","first-page":"100511","DOI":"10.1016\/j.xgen.2024.100511","volume":"4","author":"DJ Woodcock","year":"2024","unstructured":"Woodcock DJ, et al. Genomic evolution shapes prostate cancer disease type. Cell Genom. 2024;4(3):100511.","journal-title":"Cell Genom"},{"issue":"9","key":"4169_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41585-020-0349-1","volume":"17","author":"MM Kouspou","year":"2020","unstructured":"Kouspou MM, et al. The movember prostate cancer landscape analysis: an assessment of unmet research needs. Nat Rev Urol. 2020;17(9):499\u2013512.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"4169_CR9","doi-asserted-by":"publisher","first-page":"189080","DOI":"10.1016\/j.bbcan.2024.189080","volume":"1879","author":"RI Skotheim","year":"2024","unstructured":"Skotheim RI, et al. Prostate cancer: molecular aspects, consequences, and opportunities of the multifocal nature. Biochim Biophys Acta Rev Cancer. 2024;1879(2):189080.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"4169_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. Machine learning-based integration develops an immune-derived LncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816.","journal-title":"Nat Commun"},{"key":"4169_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010008","author":"L Zhang","year":"2024","unstructured":"Zhang L, et al. Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma. J Immunother Cancer. 2024;12(10):e010008. https:\/\/doi.org\/10.1136\/jitc-2024-010008","journal-title":"J Immunother Cancer"},{"key":"4169_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-016-0004","author":"HT Nia","year":"2016","unstructured":"Nia HT, et al. Solid stress and elastic energy as measures of tumour mechanopathology. Nat Biomed Eng. 2016;1:0004. https:\/\/doi.org\/10.1038\/s41551-016-0004","journal-title":"Nat Biomed Eng"},{"issue":"7","key":"4169_CR13","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41556-018-0131-2","volume":"20","author":"H Mohammadi","year":"2018","unstructured":"Mohammadi H, Sahai E. Mechanisms and impact of altered tumour mechanics. Nat Cell Biol. 2018;20(7):766\u201374.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"4169_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41568-023-00656-5","volume":"24","author":"E Cambria","year":"2024","unstructured":"Cambria E, et al. Linking cell mechanical memory and cancer metastasis. Nat Rev Cancer. 2024;24(3):216\u201328.","journal-title":"Nat Rev Cancer"},{"key":"4169_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz0868","author":"HT Nia","year":"2020","unstructured":"Nia HT, Munn LL, Jain RK. Physical traits of cancer. Science. 2020;370(6516):eaaz0868. https:\/\/doi.org\/10.1126\/science.aaz0868","journal-title":"Science"},{"issue":"11","key":"4169_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nnano.2012.167","volume":"7","author":"M Plodinec","year":"2012","unstructured":"Plodinec M, et al. The Nanomechanical signature of breast cancer. Nat Nanotechnol. 2012;7(11):757\u201365.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"4169_CR17","first-page":"245","volume":"161","author":"K Ohashi","year":"2017","unstructured":"Ohashi K, Fujiwara S, Mizuno K. Roles of the cytoskeleton, cell adhesion and rho signalling in mechanosensing and mechanotransduction. J Biochem. 2017;161(3):245\u201354.","journal-title":"J Biochem"},{"key":"4169_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809003","author":"J Insua-Rodriguez","year":"2018","unstructured":"Insua-Rodriguez J, et al. Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis. EMBO Mol Med. 2018;10(10):e9003. https:\/\/doi.org\/10.15252\/emmm.201809003","journal-title":"EMBO Mol Med"},{"issue":"1","key":"4169_CR19","doi-asserted-by":"publisher","first-page":"e2209260120","DOI":"10.1073\/pnas.2209260120","volume":"120","author":"X He","year":"2023","unstructured":"He X, et al. Extracellular matrix physical properties govern the diffusion of nanoparticles in tumor microenvironment. Proc Natl Acad Sci U S A. 2023;120(1):e2209260120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"4169_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s11427-024-2622-1","volume":"67","author":"P Zhang","year":"2024","unstructured":"Zhang P, et al. The genomic and Immunogenomic landscape of mechanics pathway informs clinical prognosis and response to mechanotherapy. Sci China Life Sci. 2024;67(8):1549\u201362.","journal-title":"Sci China Life Sci"},{"issue":"3","key":"4169_CR21","doi-asserted-by":"publisher","first-page":"lqaa078","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genom Bioinform. 2020;2(3):lqaa078.","journal-title":"NAR Genom Bioinform"},{"issue":"1","key":"4169_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, et al. Pan-cancer Immunogenomic analyses reveal Genotype-Immunophenotype relationships and predictors of response to checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"issue":"12","key":"4169_CR23","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. Consensusclusterplus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"7","key":"4169_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41419-024-06873-6","volume":"15","author":"G Zhu","year":"2024","unstructured":"Zhu G, et al. Myofibroblasts derived type V collagen promoting tissue mechanical stress and facilitating metastasis and therapy resistance of lung adenocarcinoma cells. Cell Death Dis. 2024;15(7):493.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4169_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"key":"4169_CR26","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. OncoPredict: an R package for predicting or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260.","DOI":"10.1093\/bib\/bbab260"},{"issue":"1","key":"4169_CR27","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","volume":"3","author":"B Dong","year":"2020","unstructured":"Dong B, et al. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer. Commun Biol. 2020;3(1):778.","journal-title":"Commun Biol"},{"issue":"1","key":"4169_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol. 2021;23(1):87\u201398.","journal-title":"Nat Cell Biol"},{"issue":"7","key":"4169_CR29","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, et al. Comprehensive integration of Single-Cell data. Cell. 2019;177(7):1888\u2013e190221.","journal-title":"Cell"},{"issue":"1","key":"4169_CR30","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using cellchat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"key":"4169_CR31","doi-asserted-by":"publisher","first-page":"1582992","DOI":"10.3389\/fimmu.2025.1582992","volume":"16","author":"W Li","year":"2025","unstructured":"Li W, et al. Landscape analysis of matrix metalloproteinases reveals key prognostic markers for prostate cancer. Front Immunol. 2025;16:1582992.","journal-title":"Front Immunol"},{"issue":"2","key":"4169_CR32","doi-asserted-by":"publisher","first-page":"188513","DOI":"10.1016\/j.bbcan.2021.188513","volume":"1875","author":"P Ahluwalia","year":"2021","unstructured":"Ahluwalia P, Kolhe R, Gahlay GK. The clinical relevance of gene expression based prognostic signatures in colorectal cancer. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188513.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"S1","key":"4169_CR33","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1038\/modpathol.2017.167","volume":"31","author":"DJ Grignon","year":"2018","unstructured":"Grignon DJ. Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens. Mod Pathol. 2018;31(S1):S96\u2013109.","journal-title":"Mod Pathol"},{"issue":"3","key":"4169_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.juro.2016.03.152","volume":"196","author":"K Fleshner","year":"2016","unstructured":"Fleshner K, et al. Clinical findings and treatment outcomes in patients with extraprostatic extension identified on prostate biopsy. J Urol. 2016;196(3):703\u20138.","journal-title":"J Urol"},{"issue":"1","key":"4169_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10555-020-09950-2","volume":"40","author":"WL Harryman","year":"2021","unstructured":"Harryman WL, et al. Cohesive cancer invasion of the biophysical barrier of smooth muscle. Cancer Metastasis Rev. 2021;40(1):205\u201319.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"4169_CR36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00330-009-1577-1","volume":"20","author":"A Surov","year":"2010","unstructured":"Surov A, et al. Skeletal muscle metastases: primary tumours, prevalence, and radiological features. Eur Radiol. 2010;20(3):649\u201358.","journal-title":"Eur Radiol"},{"issue":"1","key":"4169_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1200\/JCO.2016.69.1584","volume":"35","author":"TM Beer","year":"2017","unstructured":"Beer TM, et al. Randomized, Double-Blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic Chemotherapy-Naive Castration-Resistant prostate cancer. J Clin Oncol. 2017;35(1):40\u20137.","journal-title":"J Clin Oncol"},{"issue":"10","key":"4169_CR38","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.ccell.2023.09.006","volume":"41","author":"M Zhu","year":"2023","unstructured":"Zhu M, et al. Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden. Cancer Cell. 2023;41(10):1731\u2013e17488.","journal-title":"Cancer Cell"},{"issue":"3","key":"4169_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.eururo.2021.04.029","volume":"80","author":"HH Cheng","year":"2021","unstructured":"Cheng HH. Molecular subtyping in the neoadjuvant setting in prostate cancer: envisioning the possibilities. Eur Urol. 2021;80(3):304\u20135.","journal-title":"Eur Urol"},{"issue":"5","key":"4169_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cac2.12294","volume":"42","author":"H Zhou","year":"2022","unstructured":"Zhou H, et al. Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis. Cancer Commun (Lond). 2022;42(5):374\u2013400.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"4169_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4161\/intv.21223","volume":"1","author":"B Weigelin","year":"2012","unstructured":"Weigelin B, Bakker GJ, Friedl P. Intravital third harmonic generation microscopy of collective melanoma cell invasion: principles of interface guidance and microvesicle dynamics. Intravital. 2012;1(1):32\u201343.","journal-title":"Intravital"},{"key":"4169_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcdb.2018.07.014","volume":"93","author":"L Beunk","year":"2019","unstructured":"Beunk L, et al. Cancer invasion into musculature: Mechanics, molecules and implications. Semin Cell Dev Biol. 2019;93:36\u201345.","journal-title":"Semin Cell Dev Biol"},{"key":"4169_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2016.12.009","volume":"57\u201358","author":"A Pozzi","year":"2017","unstructured":"Pozzi A, Yurchenco PD, Iozzo RV. The nature and biology of basement membranes. Matrix Biol. 2017;57\u201358:1\u201311.","journal-title":"Matrix Biol"},{"issue":"6","key":"4169_CR44","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3892\/mmr.2014.2113","volume":"9","author":"K Imanishi","year":"2014","unstructured":"Imanishi K, et al. Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cells. Mol Med Rep. 2014;9(6):2159\u201365.","journal-title":"Mol Med Rep"},{"issue":"Suppl 2","key":"4169_CR45","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1038\/modpathol.2009.1","volume":"22","author":"L Cheng","year":"2009","unstructured":"Cheng L, et al. Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol. 2009;22(Suppl 2):S70\u201395.","journal-title":"Mod Pathol"},{"issue":"1","key":"4169_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.eururo.2010.01.015","volume":"58","author":"D Tilki","year":"2010","unstructured":"Tilki D, et al. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Eur Urol. 2010;58(1):112\u20137.","journal-title":"Eur Urol"},{"issue":"29","key":"4169_CR47","doi-asserted-by":"publisher","first-page":"e4165","DOI":"10.1097\/MD.0000000000004165","volume":"95","author":"WH Zhang","year":"2016","unstructured":"Zhang WH, et al. Comparison between superficial muscularis propria and deep muscularis propria infiltration in gastric cancer patients: A retrospective cohort study. Med (Baltim). 2016;95(29):e4165.","journal-title":"Med (Baltim)"},{"issue":"18","key":"4169_CR48","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1158\/0008-5472.CAN-19-0868","volume":"79","author":"CS Rubenstein","year":"2019","unstructured":"Rubenstein CS, et al. Gene editing of alpha6 integrin inhibits muscle invasive networks and increases Cell-Cell biophysical properties in prostate cancer. Cancer Res. 2019;79(18):4703\u201314.","journal-title":"Cancer Res"},{"issue":"5","key":"4169_CR49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ar.23330","volume":"299","author":"KM Mak","year":"2016","unstructured":"Mak KM, Png CY, Lee DJ. Type V collagen in health, disease, and fibrosis. Anat Rec (Hoboken). 2016;299(5):613\u201329.","journal-title":"Anat Rec (Hoboken)"},{"issue":"10","key":"4169_CR50","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.1007\/s13277-014-2281-6","volume":"35","author":"T Nardo","year":"2014","unstructured":"Nardo T, et al. Adhesion to type V collagen enhances staurosporine-induced apoptosis of adrenocortical cancer cells. Tumour Biol. 2014;35(10):9949\u201355.","journal-title":"Tumour Biol"},{"issue":"3","key":"4169_CR51","first-page":"263","volume":"59","author":"JJ Zhang","year":"2018","unstructured":"Zhang JJ, et al. The pro-alpha1(V) collagen gene (Col5a1) is coordinately regulated by miR-29b with core promoter in cultured cells. Connect Tissue Res. 2018;59(3):263\u201373.","journal-title":"Connect Tissue Res"},{"issue":"23","key":"4169_CR52","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41388-024-03030-3","volume":"43","author":"X Chen","year":"2024","unstructured":"Chen X, et al. COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk. Oncogene. 2024;43(23):1742\u201356.","journal-title":"Oncogene"},{"issue":"10","key":"4169_CR53","doi-asserted-by":"publisher","first-page":"6907","DOI":"10.1002\/jcp.30350","volume":"236","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Overexpressed COL5A1 is correlated with tumor progression, Paclitaxel resistance, and tumor-infiltrating immune cells in ovarian cancer. J Cell Physiol. 2021;236(10):6907\u201319.","journal-title":"J Cell Physiol"},{"key":"4169_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133244","author":"M Yang","year":"2022","unstructured":"Yang M, et al. COL5A1 promotes the progression of gastric cancer by acting as a ceRNA of miR-137-3p to upregulate FSTL1 expression. Cancers (Basel). 2022;14(13):3244. https:\/\/doi.org\/10.3390\/cancers14133244","journal-title":"Cancers (Basel)"},{"key":"4169_CR55","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2147\/CMAR.S188216","volume":"11","author":"G Feng","year":"2019","unstructured":"Feng G, et al. Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma. Cancer Manag Res. 2019;11:1263\u201374.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"4169_CR56","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2020.06.030","volume":"182","author":"T Yokota","year":"2020","unstructured":"Yokota T, et al. Type V collagen in Scar tissue regulates the size of Scar after heart injury. Cell. 2020;182(3):545\u2013e56223.","journal-title":"Cell"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04169-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04169-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04169-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:03:07Z","timestamp":1770987787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04169-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4169"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04169-7","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The examinations of human samples were approved by the Institutional Ethics Committee of Chongqing Medical University (Approval No.2021\u2009\u2212\u2009660).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}